These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34307279)

  • 1. Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS.
    Li J; Li S; Cao W; Wang Z; Liang Z; Fu W; Zhao J
    Front Public Health; 2021; 9():679540. PubMed ID: 34307279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China.
    Wang X; Zhang X; He J
    Biosci Trends; 2020 Mar; 14(1):3-8. PubMed ID: 32062645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of China's COVID-19 prevention and control efforts on outbreaks of influenza.
    Li Q; Wang J; Lv H; Lu H
    Biosci Trends; 2021 Jul; 15(3):192-195. PubMed ID: 34176827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
    Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
    Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.
    Li M
    Glob Public Health; 2021; 16(8-9):1223-1236. PubMed ID: 33891518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from the comparisons of SARS-CoV and COVID-19 outbreaks: The evidence-based experience of epidemic prevention in China.
    Liu WY; Chuang YC; Liu TJ; Chien CW; Tung TH
    Medicine (Baltimore); 2021 Feb; 100(6):e24650. PubMed ID: 33578592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
    Peeri NC; Shrestha N; Rahman MS; Zaki R; Tan Z; Bibi S; Baghbanzadeh M; Aghamohammadi N; Zhang W; Haque U
    Int J Epidemiol; 2020 Jun; 49(3):717-726. PubMed ID: 32086938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response.
    Nkengasong J
    Nat Med; 2020 Mar; 26(3):310-311. PubMed ID: 31988464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mobile Health Platform to Disseminate Validated Institutional Measurements During the COVID-19 Outbreak: Utilization-Focused Evaluation Study.
    Zamberg I; Manzano S; Posfay-Barbe K; Windisch O; Agoritsas T; Schiffer E
    JMIR Public Health Surveill; 2020 Apr; 6(2):e18668. PubMed ID: 32250958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "A community system": A critical foundation for the epidemic prevention and control of SARS-CoV-2.
    Zhang X; Yang S
    Int J Health Plann Manage; 2020 Sep; 35(5):1246-1249. PubMed ID: 32677114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Coronavirus Pandemic: What Does the Evidence Show?
    Paudel S; Dangal G; Chalise A; Bhandari TR; Dangal O
    J Nepal Health Res Counc; 2020 Apr; 18(1):1-9. PubMed ID: 32335585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Coronavirus Disease 2019 (COVID-19) Pandemic.
    Baloch S; Baloch MA; Zheng T; Pei X
    Tohoku J Exp Med; 2020 Apr; 250(4):271-278. PubMed ID: 32321874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ongoing COVID-19 Pandemic: A Concise but Updated Comprehensive Review.
    Wang C; Xiao X; Feng H; Hong Z; Li M; Tu N; Li X; Wang K; Bu L
    Curr Microbiol; 2021 May; 78(5):1718-1729. PubMed ID: 33847795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. China's Fight Against COVID-19: What We Have Done and What We Should Do Next?
    Cheng S; Zhao Y; Kaminga AC; Zhang X; Xu H
    Front Public Health; 2022; 10():548056. PubMed ID: 35844877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 16. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbreaks and epidemics.
    Kamel Boulos MN; Geraghty EM
    Int J Health Geogr; 2020 Mar; 19(1):8. PubMed ID: 32160889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using WeChat, a Chinese Social Media App, for Early Detection of the COVID-19 Outbreak in December 2019: Retrospective Study.
    Wang W; Wang Y; Zhang X; Jia X; Li Y; Dang S
    JMIR Mhealth Uhealth; 2020 Oct; 8(10):e19589. PubMed ID: 32931439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) in Dentistry. Management of Biological Risk in Dental Practice.
    Lo Giudice R
    Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32354081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Novel Coronavirus: A Bird's Eye View.
    Habibzadeh P; Stoneman EK
    Int J Occup Environ Med; 2020 Apr; 11(2):65-71. PubMed ID: 32020915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.
    Zhang P
    Front Public Health; 2021; 9():610824. PubMed ID: 33981659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.